FSLR First Solar Inc

Previous close
$195.32
Est. 12 months change
+23.73%
Projected Price
$242.14

Profitability Metrics

Return on Equity (ROE)
17.55%
Return on Assets (ROA)
9.90%
Return on Invested Capital (ROIC)
17.84%
Weighted Average Cost of Capital (WACC)
13.19%
ROIC - WACC
4.65%
Updated : 2026-04-03 21:25 ET

Valuation Metrics

P/E Ratio
13.75
Forward P/E
10.87
PEG Ratio
0.43
Debt Current Ratio
2.67

Growth & Cash Flow

Gross Margin
40.62%
Operating Margin
30.60%
FCF Margin
22.75%
TTM Revenue Growth
11.15%
Projected 12M EPS Growth
26.48%

Price Change

Price % from 50 SMA
-8.36%
Price % from 200 SMA
-10.54%
6 Months
-15.86%
1 Year
50.45%
2 Years
16.84%
Click here to see the list of ETFs containing FSLR as a top holding :First Solar Inc ETFs

Analysis

Company Overview

First Solar manufactures advanced thin-film photovoltaic solar panels and develops utility-scale solar power projects primarily in the United States. Sector: Technology.

Overview

First Solar Inc (FSLR) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 17.84%, WACC is 13.19%, and the economic spread is 4.65%. On balance, the economic spread is positive but compressed — adequate for value preservation, less convincing for aggressive compounding. Supporting metrics show ROE at 17.55% and ROA at 9.90%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

Valuation

On an earnings multiple basis, trailing P/E of 13.75, forward P/E of 10.87, PEG of 0.43. The gap between trailing and forward multiples is not especially wide, suggesting the market is pricing a steadier earnings path rather than a sharp near-term re-rating. At this PEG level, growth-adjusted valuation looks attractive — the market appears to be paying a reasonable price for the earnings growth embedded in estimates. A current ratio of 2.67 across the company reflects strong short-term liquidity. Combining multiples and liquidity, the company appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 40.62%, operating margin at 30.60%, and free cash flow margin at 22.75%. Gross margins are healthy, suggesting solid pricing power across the company. At this operating margin level, the company demonstrates strong operational discipline and meaningful earnings leverage. At this FCF margin level, the company demonstrate good cash generation relative to the revenue base. Read as a whole, the margin picture suggests a business with strengths in parts but no clear margin dominance end-to-end.

Growth & Forward Outlook

Revenue trends and analyst expectations together suggest: TTM revenue growth of 11.15% indicating steady top-line growth at the company level, while the estimated 12-month price change of 23.97%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 26.5%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. There is always distance between what is reported and what is priced; the question of whether that distance is closing or widening is what makes the setup interesting. In either direction, the fundamental driver of returns will be whether the company can sustain the trajectory that is already being priced. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The aggregate picture across capital efficiency, valuation, growth, and cash generation builds a compelling case.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.